Skip to content

Blood Pressure Assessment in Waiting Room During Pregnancy

Automatic Blood Pressure Assessment in Waiting Room During Pregnancy Compare to 24-h Ambulatory Blood Pressure Measurement

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06248463
Acronym
WAPA-Pregnan
Enrollment
659
Registered
2024-02-08
Start date
2024-11-01
Completion date
2026-07-01
Last updated
2024-02-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension, Pregnancy Induced Hypertension

Keywords

Hypertension in pregnancy., Blood Pressure measurement.

Brief summary

The goal of this observational study is to compare in healthy pregnant women during the first trimester. The main question it aims to answer are: Accuracy of measuring automatically Blood Pressure (BP) at appointment compared to 24 Hour Ambulatory Blood Pressure Monitor (ABPM). Participants will be BP measured with homologated device every 3 minutes in waiting room for 20 minutes. Researchers will compare Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP) in clinical visit to see if are comparable to ABPM.

Detailed description

659 pregnant women will be recruitment if they In with SBP readings above 130 mmHg in office or the presence of a risk factor for eclampsia: (hypertensive disease in previous pregnancy, chronic hypertension, chronic renal disease, diabetes mellitus, or autoimmune disease) or any two moderate-risk factors (nulliparity, age ≥40 years, BMI ≥35 kg/m2, family history of PE, or interpregnancy interval \>10 years). Measured of BP will be performance in waiting room for 20 minutes every 3 minutes and report by an mobile app. After 24h-ABPM device will be implanted. Results of SBP and DBP obtained in office will be compared with 24-h, diurnal and nocturnal SBP/DBP mean. BP will be measured automatically and repeatedly every 3 minutes in the waiting room for 20 minutes. Subsequently, a SpaceLab ABPM monitor will be implanted. The SBP and DBP results obtained in the waiting room will be compared with the ABPM results. Clinical data related to eclampsia and maternal and newborn pregnancy outcomes will be collected from all patients.

Interventions

DIAGNOSTIC_TESTBP measurement in waiting room for 20 minutes

Measured of BP will be performance in waiting room for 20 minutes every 3 minutes and report by an mobile app. After 24h-ABPM device will be implanted. Results of SBP and DBP obtained in office will be compared with 24-h, diurnal and nocturnal SBP/DBP mean. BP will be measured automatically and repeatedly every 3 minutes in the waiting room for 20 minutes. Subsequently, a SpaceLab ABPM monitor will be implanted.

Sponsors

University of Salamanca
CollaboratorOTHER
Fundación para la Formación e Investigación de los Profesionales de la Salud de Extremadura
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

Woman during the first 12 weeks of pregnancy Maternal age\>35 Nulliparity Previous history of hypertension Short and long interpregnancy interval Use of assisted reproductive technologies Family history of preeclampsia Obesity. BMI\>30. Hyperglycemia Renal disease

Exclusion criteria

Any inability to perform 24-h ambulatory BP measurement

Design outcomes

Primary

MeasureTime frameDescription
Differences in Blood Pressure between office and 24- Ambulatory Blood Pressure Meassurement (24-h ABPM)10 mounthsConcordance of Systolic and Diastolic Blood Pressure mean between waiting room and 24-h ABMP measurements
Maternal10 monthsCardiovascular events, preeclampsia, abruptio, cesarean delivery, hemorrhage,pulmonary edema, death
Newborn10 montsGrowth restriction, preterm delivery, congenital anomalies, stillbirth, neonatal death.

Contacts

Primary ContactJUAN F SANCHEZ MUÑOZ-TORRERO, MD
juanf.sanchezm@gmail.com0034656259939
Backup ContactJONHATAN GOMEZ RAJA, MD
jonathan.gomez@fundesalud.es34 620962640

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026